Investors Grab MNLO Even Lower Than Its Secondary Stock Offering

Looking back to 6 days ago, Menlo Therapeutics Inc (MNLO) priced a 27,050,000 share secondary stock offering at $1.85 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.